# MISSILE-NSCLC (NCT02136355)

> A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: early-stage non-small cell lung cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02136355
- Phase: NA
- Status: COMPLETED
- Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Conditions: Non Small Cell Lung Cancer
- Interventions: Stereotactic Body Radiation Therapy plus Surgery
- Enrollment: 40
- Primary outcome: Tumor response

## Indexed commentary on MISSILE-NSCLC so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 4 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=missile-nsclc-nct02136355